Andrew Karter to Angiotensin Receptor Antagonists
This is a "connection" page, showing publications Andrew Karter has written about Angiotensin Receptor Antagonists.
Connection Strength
0.073
-
Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes. J Gen Intern Med. 2004 Jun; 19(6):669-75.
Score: 0.056
-
Who is tested for diabetic kidney disease and who initiates treatment? The Translating Research Into Action For Diabetes (TRIAD) Study. Diabetes Care. 2006 Aug; 29(8):1733-8.
Score: 0.016